This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the infectious disease testing market during the next five years. The report reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.
The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the worlds major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.
Infectious Diseases Analyzed in the Report
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.
Current and Emerging Products
- In-depth examination of over 100 major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.
- Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.
- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for infectious disease testing.
- Companies developing or marketing infectious disease diagnostic products by individual test.
Opportunities and Strategic Recommendations
- Emerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
Contains 950 pages and 125 tables
SIMILAR MARKET STUDIES
Europe Automated Microbiology Market: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics-Supplier and Shares Strategies, Country Volume and Sales Segment Forecasts
Complete report $19,850. DataPack (test volumes, sales forecasts, supplier shares) $12,900. VPGMarketResearch.com's new report is a five-country strategic analysis of major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the major European countries (France, Germany, Italy, Spain, UK); reviews current ...
July 2016 | $0 | View Details >>
About Enteric Diseases Enteric diseases are infections caused by ingested bacteria and viruses. Direct contact with contaminated feces or vomit is the secondary mode of contracting enteric ailments. Symptoms of enteric diseases include stomach pain, vomiting, diarrhea, nausea, weight loss, anorexia, and fever. Enteric diseases may lead to stunted growth, malnutrition, ...
July 2016 | $2500 | View Details >>
This new report provides analysis of Cocaine testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
November 2014 | $0 | View Details >>
Complete report $32,500. DataPack test volumes, sales forecasts, supplier shares $21,100. Summary This comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global coagulation testing market during the next five years. ...
November 2013 | $21100 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research